Systemic Lupus and Adverse Pregnancy Outcome

Systemic Lupus Erythematosus Clinical Trial

Official title:

Systemic Lupus and Pregnancy Outcome in Benisuef Localities

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

• NCT number: NCT03171103
• Other study ID #: 2505
• Status: Enrolling by invitation
• Phase: N/A
• First received: May 25, 2017
• Last updated: May 27, 2017
• Start date: May 1, 2017
• Est. completion date: May 1, 2020

Study information

• Verified date: May 2017
• Source: Beni-Suef University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

prospective analytical study of all pregnant ladies with systemic lupus in Beni-suef localities

Recruitment information / eligibility

• Status: Enrolling by invitation
• Enrollment: 100
• Est. completion date: May 1, 2020
• Est. primary completion date: May 1, 2020
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years to 45 Years

Eligibility

Inclusion Criteria:

• all pregnant ladies with settled diagnosis of systemic lupus

• all pregnant ladies who first diagnosed as systemic lupus during current pregnancy

Exclusion Criteria:

Related Conditions & MeSH terms

• Lupus Erythematosus, Systemic
• Pregnancy Complications
• Systemic Lupus Erythematosus

Locations

Country	Name	City	State
Egypt	Faculty of Medicine	Beni-suef

Sponsors (1)

Lead Sponsor	Collaborator
Beni-Suef University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	maternal outcome	Number of patients who have abortion,preterm labor,preeclampsia,eclampsia,accidental hemorrhage,oligohydramnios	3 years
Secondary	fetal outcome	Number of patients who have abortion,prematurity,Intrauterine growth restriction,intrauterine fetal death,still birth,low birth weight,neonatal death	3 years